MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency

MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency
复制标题

DOI:
10.1210/jc.2016-2565
复制
发表时间:
2017-02-01
影响因子:
5.8
通讯作者:
Rajkovic, Aleksandar
Rajkovic, Aleksandar
中科院分区:
医学2区
文献类型:
--
作者:
Desai, Swapna;Wood-Trageser, Michelle;Rajkovic, Aleksandar

文献摘要

被引文献

相似文献

目的:评估原发性卵巢功能不全(POI)参与者中微小染色体维持8(MCM 8)和微小染色体维持9(MCM 9)、与MCM 8-MCM 9相关的其他基因和DNA损伤修复(DDR)途径中的变体(包括双等位基因致病性变体)的频率。对POI参与者中的MCM 8、MCM 9和编码与生殖衰老有关的DDR蛋白的基因进行测序。所有患者均在40岁之前被诊断为POI,并表现为卵泡刺激素水平升高。干预措施:无。主要结果测量:未鉴定的MCM 8、MCM 9中的核苷酸变异,以及被认为参与DNA损伤反应途径和/或与生殖衰老有关的基因。结果:MCM 8在155名POI参与者中测序,而MCM 9在151名参与者中测序。155名参与者中有3名(2%)携带可能具有破坏性的杂合MCM 8变异,而151名参与者中有7名(5%)携带可能具有破坏性的杂合MCM 9变异。一名参与者在MCM 9中携带了一种新的纯合变体c.1651C>.T,p.Gln551*,预计该变体将在外显子9中引入一个提前终止密码子。在1名受试者中鉴定出MCM 8和MCM 9中的双等位基因损伤杂合变体。共有10名参与者携带破坏性杂合变异的MCM 8或MCM 9,2个人携带杂合破坏性变异的基因与MCM 8或MCM 9或DDR pathway.Conclusions:我们确定了一个显着的数量潜在的破坏性和新的变异MCM 8和MCM 9参与者POI和检查多等位基因关联与DDR和MCM 8-MCM 9相互作用基因的变异。
Objective: To assess the frequency of variants, including biallelic pathogenic variants, in minichromosome maintenance 8 (MCM8) and minichromosome maintenance 9 (MCM9), other genes related to MCM8-MCM9, and DNA damage repair (DDR) pathway in participants with primary ovarian insufficiency (POI).Design: MCM8, MCM9, and genes encoding DDR proteins that have been implicated in reproductive aging were sequenced among POI participants.Setting: Academic research institution.articipants: All were diagnosed with POI prior to age 40 years and presented with elevated folliclestimulating hormone levels.Interventions: None.Main Outcome Measures: Weidentified nucleotide variants inMCM8, MCM9, and genes thought to be involved in the DNA damage response pathway and/or implicated in reproductive aging.Results: MCM8 was sequenced in 155 POI participants, whereas MCM9 was sequenced in 151 participants. Three of 155 (2%) participants carried possibly damaging heterozygous variants in MCM8, whereas 7 of 151 (5%) individuals carried possibly damaging heterozygous variants in MCM9. One participant carried a novel homozygous variant, c.1651C>.T, p.Gln551*, in MCM9, which is predicted to introduce a premature stop codon in exon 9. Biallelic damaging heterozygous variants in both MCM8 and MCM9 were identified in 1 participant. Of a total of 10 participants carrying damaging heterozygous variants in either MCM8 or MCM9, 2 individuals carried heterozygous damaging variants in genes associated with either MCM8 or MCM9 or the DDR pathway.Conclusions: We identified a significant number of potentially damaging and novel variants in MCM8 and MCM9 among participants with POI and examined multiallelic association with variants in DDR and MCM8-MCM9 interactome genes.